Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release.

Trier DA, Gank KD, Kupferwasser D, Yount NY, French WJ, Michelson AD, Kupferwasser LI, Xiong YQ, Bayer AS, Yeaman MR.

Infect Immun. 2008 Dec;76(12):5706-13. doi: 10.1128/IAI.00935-08. Epub 2008 Sep 29.

2.

Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction.

Kupferwasser LI, Amorn AM, Kapoor N, Lee MS, Kar S, Cercek B, Dohad S, Mirocha J, Forrester JS, Shah PK, Makkar RR.

Catheter Cardiovasc Interv. 2007 Jul 1;70(1):1-8.

PMID:
17580366
3.

Percutaneous coronary intervention in unprotected left main disease: a status report.

Kupferwasser LI, Lee MS, Schapira JN, Makkar RR.

Minerva Cardioangiol. 2006 Oct;54(5):633-41. Review.

PMID:
17019399
4.

Salicylic acid activates sigma factor B by rsbU-dependent and -independent mechanisms.

Palma M, Bayer A, Kupferwasser LI, Joska T, Yeaman MR, Cheung A.

J Bacteriol. 2006 Aug;188(16):5896-903.

5.

Low-level resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein 1 in vitro associated with qacA gene carriage is independent of multidrug efflux pump activity.

Bayer AS, Kupferwasser LI, Brown MH, Skurray RA, Grkovic S, Jones T, Mukhopadhay K, Yeaman MR.

Antimicrob Agents Chemother. 2006 Jul;50(7):2448-54.

6.

Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans.

Yeaman MR, Cheng D, Desai B, Kupferwasser LI, Xiong YQ, Gank KD, Edwards JE Jr, Bayer AS.

Antimicrob Agents Chemother. 2004 Aug;48(8):3051-6.

7.

Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus.

Kupferwasser LI, Yeaman MR, Nast CC, Kupferwasser D, Xiong YQ, Palma M, Cheung AL, Bayer AS.

J Clin Invest. 2003 Jul;112(2):222-33.

9.

[Culture-negative endocarditis: etiology, diagnosis, management and therapy].

Kupferwasser LI, Bayer AS.

Herz. 2001 Sep;26(6):398-408. Review. German.

PMID:
11683070
10.

Diagnosis of culture-negative endocarditis: the role of the Duke criteria and the impact of transesophageal echocardiography.

Kupferwasser LI, Darius H, Müller AM, Martin C, Mohr-Kahaly S, Erbel R, Meyer J.

Am Heart J. 2001 Jul;142(1):146-52.

PMID:
11431671
11.

Echocardiography predicts embolic events in infective endocarditis.

Shapiro S, Kupferwasser LI.

J Am Coll Cardiol. 2001 Mar 15;37(4):1077-9. No abstract available.

12.

Update on culture-negative endocarditis.

Kupferwasser LI, Bayer AS.

Curr Clin Top Infect Dis. 2000;20:113-33. Review. No abstract available.

PMID:
10943521
13.

Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis.

Müller AM, Cronen C, Kupferwasser LI, Oelert H, Müller KM, Kirkpatrick CJ.

J Pathol. 2000 May;191(1):54-60.

PMID:
10767719
14.

Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus.

Kupferwasser LI, Skurray RA, Brown MH, Firth N, Yeaman MR, Bayer AS.

Antimicrob Agents Chemother. 1999 Oct;43(10):2395-9.

17.

The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events.

Kupferwasser LI, Hafner G, Mohr-Kahaly S, Erbel R, Meyer J, Darius H.

J Am Coll Cardiol. 1999 Apr;33(5):1365-71.

Supplemental Content

Loading ...
Support Center